Cardio Diagnostics Holdings Stock Price Patterns
| CDIOW Stock | USD 0.05 0 5.85% |
Momentum 42
Sell Extended
Oversold | Overbought |
Quarterly Revenue Growth (0.57) |
Using Cardio Diagnostics hype-based prediction, you can estimate the value of Cardio Diagnostics Holdings from the perspective of Cardio Diagnostics response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Cardio Diagnostics to buy its stock at a price that has no basis in reality. In that case, they are not buying Cardio because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Cardio Diagnostics after-hype prediction price | USD 0.06 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Cardio Diagnostics Basic Forecasting Models to cross-verify your projections. Cardio Diagnostics After-Hype Price Density Analysis
As far as predicting the price of Cardio Diagnostics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Cardio Diagnostics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Cardio Diagnostics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Cardio Diagnostics Estimiated After-Hype Price Volatility
In the context of predicting Cardio Diagnostics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Cardio Diagnostics' historical news coverage. Cardio Diagnostics' after-hype downside and upside margins for the prediction period are 0.00 and 12.37, respectively. We have considered Cardio Diagnostics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Cardio Diagnostics is out of control at this time. Analysis and calculation of next after-hype price of Cardio Diagnostics is based on 3 months time horizon.
Cardio Diagnostics Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Cardio Diagnostics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Cardio Diagnostics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Cardio Diagnostics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
2.45 | 12.25 | 0.01 | 0.19 | 5 Events / Month | 6 Events / Month | In about 5 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
0.05 | 0.06 | 32.16 |
|
Cardio Diagnostics Hype Timeline
Cardio Diagnostics is currently traded for 0.05. The entity has historical hype elasticity of 0.01, and average elasticity to hype of competition of -0.19. Cardio is estimated to increase in value after the next headline, with the price projected to jump to 0.06 or above. The average volatility of media hype impact on the company the price is over 100%. The price increase on the next news is projected to be 32.16%, whereas the daily expected return is currently at 2.45%. The volatility of related hype on Cardio Diagnostics is about 15506.33%, with the expected price after the next announcement by competition of -0.14. Cardio Diagnostics Holdings has accumulated 969.86 K in total debt. Note, when we think about Cardio Diagnostics' use of debt, we should always consider it together with its cash and equity.Assuming the 90 days horizon the next estimated press release will be in about 5 days. Check out Cardio Diagnostics Basic Forecasting Models to cross-verify your projections.Cardio Diagnostics Related Hype Analysis
Having access to credible news sources related to Cardio Diagnostics' direct competition is more important than ever and may enhance your ability to predict Cardio Diagnostics' future price movements. Getting to know how Cardio Diagnostics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Cardio Diagnostics may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| BCDA | Biocardia | (0.01) | 8 per month | 0.00 | (0.04) | 5.98 | (6.03) | 19.36 | |
| NLSP | NLS Pharmaceutics AG | (0.60) | 9 per month | 0.00 | (0.17) | 8.33 | (15.32) | 43.14 | |
| ACXP | Acurx Pharmaceuticals LLC | 0.01 | 4 per month | 0.00 | (0.18) | 9.45 | (7.89) | 49.19 | |
| APVO | Aptevo Therapeutics | 0.05 | 9 per month | 0.00 | (0.19) | 8.66 | (9.42) | 43.37 | |
| APRE | Aprea Therapeutics | (0.17) | 9 per month | 0.00 | (0.03) | 11.29 | (10.58) | 46.26 | |
| KPRX | Kiora Pharmaceuticals | 0.04 | 4 per month | 2.55 | 0.05 | 4.44 | (3.90) | 16.69 | |
| TVGN | Tevogen Bio Holdings | 0.01 | 8 per month | 0.00 | (0.09) | 10.00 | (7.89) | 26.81 | |
| INAB | In8bio Inc | (0.16) | 7 per month | 4.92 | 0.03 | 14.29 | (8.88) | 37.96 | |
| HCWB | HCW Biologics | 0.1 | 6 per month | 0.00 | (0.26) | 8.72 | (11.97) | 42.74 | |
| RNAZ | Transcode Therapeutics | (0.06) | 6 per month | 4.91 | 0.04 | 16.20 | (7.47) | 35.66 |
Cardio Diagnostics Additional Predictive Modules
Most predictive techniques to examine Cardio price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Cardio using various technical indicators. When you analyze Cardio charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Cardio Diagnostics Predictive Indicators
The successful prediction of Cardio Diagnostics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Cardio Diagnostics Holdings, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Cardio Diagnostics based on analysis of Cardio Diagnostics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Cardio Diagnostics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Cardio Diagnostics's related companies. | 2024 | 2025 | 2026 (projected) | Days Sales Outstanding | 194.71 | 175.24 | 120.32 | PTB Ratio | 77.41 | 89.02 | 84.57 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Cardio Stock Analysis
When running Cardio Diagnostics' price analysis, check to measure Cardio Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cardio Diagnostics is operating at the current time. Most of Cardio Diagnostics' value examination focuses on studying past and present price action to predict the probability of Cardio Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cardio Diagnostics' price. Additionally, you may evaluate how the addition of Cardio Diagnostics to your portfolios can decrease your overall portfolio volatility.